NASDAQ : BGLC

BioNexus Gene Lab Corp. — Options Chain

$1.54 USD

-$0.09 (-5.52%)

Volume
9.58K
Average Volume
99.31K
Market Capitalization
$3.1M
P/E Ratio
-1.04
Dividend Yield
0.00%
Price Target
Year High
$8.98
Year Low
$1.07
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.52
BGLC Earnings Calendar
Date EPS Estimated Time Revenue Revenue Estimated
2026-05-15 After Market Close $22842 -$
2026-04-14 After Market Close $483.76K -$
2025-11-14 After Market Close $2.54M -$
2025-08-18 After Market Close $2.26M -$
2025-05-15 After Market Close $2.14M -$
2025-04-15 After Market Close $2.52M -$
2024-11-15 After Market Close $2.63M -$
2024-08-14 After Market Close $1.97M -$
2024-05-15 After Market Close $2.38M -$
2024-03-29 After Market Close $2.27M -$
2023-11-20 After Market Close $2.55M -$
2023-08-16 After Market Close $2.57M -$
2022-11-14 After Market Close $2.58M -$
2022-08-15 After Market Close $2.49M -$
2022-05-16 After Market Close $3.03M -$
2022-04-06 After Market Close $3.25M -$
2021-11-15 After Market Close $3.58M -$
2021-08-12 After Market Close $3.09M -$
2021-05-18 After Market Close $3.45M -$
2021-03-30 After Market Close $11.36M -$
2020-11-03 After Market Close $23471 -$
2020-08-11 After Market Close $6541 -$
2020-05-08 After Market Close $3.07M -$
2020-03-31 After Market Close $53049 -$
2019-11-14 After Market Close $24173 -$
2019-08-09 After Market Close $21645 -$
2019-05-15 After Market Close $28088 -$
2018-12-31 After Market Close $9407 -$
2018-09-30 After Market Close $91625 -$
2018-06-30 After Market Close $111.3K -$
2018-03-31 After Market Close -$ -$
2017-12-31 After Market Close $64519 -$